Time Matters

Time is an invaluable resource, an ever-present thread weaving through every aspect of human existence. In healthcare, especially in oncology, time takes on a profound meaning. For patients diagnosed with cancer, every second carries weight—weight of hope, uncertainty, pain, or healing. Yet, the concept of time toxicity in cancer care remains grossly underexplored and underestimated.1 As we enter an era of precision medicine and patient-centered care, it is imperative to revisit this critical concept and place emphasis where it belongs: on alleviating the undue burden of time spent navigating the labyrinth of cancer care. Time toxicity, at its core, encompasses the cumulative and often invisible toll of time lost to cancer treatment, including frequent hospital visits, waiting times, side effects that limit daily functioning, and the psychological distress of prolonged engagement with the healthcare system.1,2 Unlike physical or financial toxicities, time toxicity is an intangible burden that profoundly affects patients’ quality of life and well-being. Despite its pervasive impact, this dimension of cancer care has received far less attention in clinical practice and research. Cancer care pathways are inherently complex, involving multidisciplinary teams, multiple appointments, and elaborate treatment regimens. For many patients, especially those in underserved or rural areas, the journey from diagnosis to treatment and survivorship becomes an odyssey characterized by time-consuming processes.3 This burden disproportionately affects vulnerable populations, including the elderly, economically disadvantaged, and those with limited social support.4 The inequities in access and the resultant time toxicity underscore the urgent need to prioritize this issue in policy and practice. Time toxicity has far-reaching implications. For patients, excessive time spent in healthcare settings can lead to missed opportunities for meaningful life activities, such as spending time with loved ones, pursuing personal goals, or engaging in work.1 This lost time compounds the existential distress that often accompanies a cancer diagnosis. For caregivers, the ripple effects of time toxicity manifest as financial strain, emotional exhaustion, and disruptions to their own lives. Clinicians, too, face challenges stemming from time toxicity. Overburdened schedules and administrative tasks detract from their ability to deliver compassionate, patient-centered care. As the healthcare system becomes more fragmented, the lack of streamlined processes exacerbates the time burden for all stakeholders. To effectively address time toxicity, we must recognize it as a core element of treatment planning and decision-making. By doing so, we can recalibrate our approach to cancer care in ways that reduce the time burden on patients and their caregivers. One critical strategy is to streamline care pathways. Leveraging technology to integrate processes can eliminate redundancies and optimize appointment scheduling.3 Innovations such as telemedicine, digital patient portals, and artificial intelligence–powered tools for symptom monitoring are already demonstrating their potential to alleviate the time spent in traditional care settings. By embracing these advancements, we can help patients reclaim valuable hours of their lives. Another essential focus is patient-centered scheduling. Understanding the unique needs and preferences of patients allows healthcare providers to tailor appointment times and reduce the disruptions caused by frequent hospital visits. Practical solutions, such as flexible scheduling and extended clinic hours, can accommodate the diverse demographics of cancer patients, ensuring that care fits seamlessly into their lives. Simplifying treatment regimens also offers significant potential. The advent of targeted therapies and immunotherapies enables the design of more efficient treatment plans that reduce the frequency and duration of sessions. Clinical trials and research must prioritize the delicate balance between therapeutic efficacy and time efficiency to minimize the temporal burden on patients. Empowering patients through education and shared decision-making is another cornerstone of tackling time toxicity. Providing transparent information about treatment options and their associated time commitments enhances patients’ sense of agency and equips them to make informed decisions about their care. By fostering open communication, we can alleviate the uncertainty that often accompanies prolonged treatment journeys. Addressing systemic barriers through policy advocacy is crucial. Transportation challenges, workforce shortages, and fragmented care pathways disproportionately exacerbate time toxicity, particularly for underserved populations. Policymakers must recognize time toxicity as a critical determinant of health equity and implement measures to address these barriers. In fact, operationalizing the concept of time toxicity requires robust research efforts. Developing validated instruments that measure and quantify this burden is a critical first step.1 Multidimensional tools capturing patient-reported outcomes, clinical data, and sociodemographic variables can provide comprehensive insights. Furthermore, longitudinal studies assessing the impact of time toxicity on treatment adherence, clinical outcomes, and quality of life are essential to inform evidence-based interventions. Oncology nurses occupy a unique position at the intersection of clinical care and patient advocacy, making them pivotal in addressing time toxicity. By prioritizing time-efficient practices, oncology nurses can: (1) provide clear and concise information about treatment schedules, potential side effects, and symptom management strategies, empowering patients to navigate their care with greater confidence and efficiency. (2) identify inefficiencies within care pathways and advocate for systemic changes to minimize time-related burdens on patients and families. Their frontline perspective is invaluable in designing patient-centered solutions. (3) offer psychosocial support, helping patients and caregivers cope with the stress of prolonged treatment journeys. (4) adopt a holistic approach that addresses not only the physical but also the psychological, social, and temporal dimensions of care. This includes coordinating with interdisciplinary teams to reduce unnecessary delays and optimize care delivery. (5) contribute to research efforts aimed at quantifying and mitigating time toxicity. Their insights into patient experiences and outcomes are critical for developing practical interventions and improving quality of care. In conclusion, the concept of time toxicity challenges us to rethink the true cost of cancer care. It compels us to see beyond the clinical and financial metrics to the lived experiences of patients and their families. By revisiting and emphasizing this underexplored aspect, we take a significant step toward humanizing oncology care. As healthcare providers, researchers, and policymakers, our collective responsibility is to ensure that time spent in cancer care is not a source of additional suffering but a pathway to healing and hope. For oncology nurses, addressing time toxicity is a call to action that aligns with the core values of their profession. By reducing the time burdens patients face, nurses can enhance quality of life, improve treatment adherence, and foster a more compassionate healthcare system. Let us make time toxicity a central pillar of oncology practice and research, placing emphasis where it truly belongs—on the lived experiences of those we serve. In doing so, we honor not just the science of medicine but the humanity of care. Chinomso Nwozichi, PhD, RN, CMSRN, OCN, FAANWellstar School of Nursing, Kennesaw State University, GeorgiaOluwaseun Martins-Akinlose, MSc, RNBabcock University School of Nursing, Ilishan RemoOgun State, NigeriaOmolabake Salako, BNSc, RNOncology Nursing Society of Nigeria, Ilishan RemoOgun State, Nigeria